TRPV1 and neoplasm: Notably, the elevated level of TRPV1 mRNA in cisplatin-resistant tumor cells was repressed by NANOG knockdown, indicating the NANOG-dependent expression of TRPV1 (Fig. 4f and Supplementary Fig. 9).